“Pivotal 4-week repeat-dose toxicity studies with 2-week recovery groups in minipig and monkey are reviewed in detail in sections 6.2.1 and 6.2.2.”
✓ VerifiedFDA pharmacology/toxicology review, p. 86Source ↗
Pivotal GLP studies
4-week IV infusion studies in minipig and monkey with 2-week recovery
“Pivotal 4-week repeat-dose toxicity studies with 2-week recovery groups in minipig and monkey are reviewed in detail in sections 6.2.1 and 6.2.2.”
✓ VerifiedFDA pharmacology/toxicology review, p. 86Source ↗
Route in tox
Intravenous (bolus and infusion)
“Repeated dose toxicity studies, up to 4 weeks duration, have been conducted in cynomolgus monkeys with administration of remimazolam by intravenous bolus and by intravenous infusion.”